丛斌斌, 王永胜. Advances in sentinel lymph node biopsy tracers for breast cancer[J]. China Oncology, 2019, 29(7): 540-544. DOI: 10.19401/j.cnki.1007-3639.2019.07.010.
Advances in sentinel lymph node biopsy tracers for breast cancer
Sentinel lymph node biopsy (SLNB) has become the standard procedure for the axillary staging in early breast cancer patients
using the radioisotope combined with blue dye. However
the extensive application of SLNB has been restricted by the poor specificity and access issue of the traditional tracer. Many novel sentinel lymph node tracers have been produced accordingly. The indocyanine green is cheap and safe to use. However
the poor penetrating power and targeting power might become the bottleneck limiting its wide application. The contrast-enhanced ultrasonography can be used to dynamically visualize lymphatic vessels and lymph nodes in real time
whereas the success rate and accuracy are relatively low. The superparamagnetic iron oxide techniques are easy to operate and could avoid iatrogenic radionuclide pollution with good application prospects.
A novel fluorescent tracer for sentinel lymph node biopsy in breast cancer
Research on the new trancer of sentinel lymph node biopsy in breast cancer patients
Guidelines for breast cancer diagnosis and treatment by China Anti-Cancer Association (2026 edition)
Progress and prospects of CENPA-driven chromosomal instability in breast cancer: mechanisms, prognostic implications, and therapeutic perspectives
A study of 30-year trends in incidence and mortality risks of breast cancer among young women in China
Related Author
吴 爽
孙 晓
丛斌斌
毕 钊
周鹏鹏
石志强
王永胜
李盼盼
Related Institution
山东省肿瘤防治研究院(山东省肿瘤医院)乳腺病中心
山东第一医科大学(山东省医学科学院)
山东大学附属山东省肿瘤医院乳腺病中心
山东省医学科学院
Department of Breast Surgery, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College